Keyphrases
Clinical Outcomes
100%
Hypertrophic Cardiomyopathy
100%
All-cause Mortality
50%
High-risk Pregnancy
33%
Major Adverse Cardiovascular Events
33%
Adverse Outcomes
16%
In(III)
16%
High Risk
16%
High-risk Population
16%
Mortality Outcomes
16%
Subgroup Analysis
16%
Non-associated
16%
Short-term Outcomes
16%
Reproductive Age
16%
10-year Follow-up
16%
Sudden Cardiac Death
16%
Acute Heart Failure
16%
Hypertrophic Obstructive Cardiomyopathy
16%
Propensity Score Matching
16%
Pregnancy History
16%
Heart Failure Exacerbation
16%
TriNetX
16%
Ventricular Tachycardia/ventricular Fibrillation
16%
Inappropriate Shock
16%
Sustained Ventricular Tachycardia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertrophic Cardiomyopathy
100%
All Cause Mortality
50%
Cardiovascular Disease
33%
Adverse Outcome
16%
Heart Ventricle Fibrillation
16%
Heart Ventricle Tachycardia
16%
Sudden Cardiac Death
16%
Acute Heart Failure
16%
High Risk Pregnancy
16%
Hypertrophic Obstructive Cardiomyopathy
16%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
100%
High Risk Population
33%
Ventricular Tachycardia
33%
Ventricular Fibrillation
33%
Sudden Cardiac Death
33%